Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer

por Ku, ShengYu, Lasorsa, Elena, Adelaiye, Remi, Ramakrishnan, Swathi, Ellis, Leigh, Pili, Roberto
Publicado 2014

EZH2 inhibition re-sensitizes multidrug resistant B-cell lymphomas to etoposide mediated apoptosis

por Smonskey, Matthew, Lasorsa, Elena, Rosario, Spencer, Kirk, Jason S., Hernandez-Ilizaliturri, Francisco J., Ellis, Leigh
Publicado 2016

Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer

por Ellis, Leigh, Ku, ShengYu, Ramakrishnan, Swathi, Lasorsa, Elena, Azabdaftari, Gizzou, Godoy, Alejandro, Pili, Roberto
Publicado 2013

Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

por Kirk, Jason S., Schaarschuch, Kevin, Dalimov, Zafardjan, Lasorsa, Elena, Ku, ShengYu, Ramakrishnan, Swathi, Hu, Qiang, Azabdaftari, Gissou, Wang, Jianmin, Pili, Roberto, Ellis, Leigh
Publicado 2014